Suppr超能文献

评估皮下用对乙酰氨基酚在老年病学和姑息治疗中的疗效和安全性(APAPSUBQ)。

Evaluation of efficacy and safety of subcutaneous acetaminophen in geriatrics and palliative care (APAPSUBQ).

机构信息

Balsam, the Lebanese Center for Palliative Care, Beirut, Lebanon.

Family Medicine Department, Saint Joseph University, Beirut, Lebanon.

出版信息

BMC Palliat Care. 2022 Mar 26;21(1):42. doi: 10.1186/s12904-022-00934-3.

Abstract

INTRODUCTION

Subcutaneous infusion (SC) or hypodermoclysis is an old perfusion technique that is often used off-label although it has been shown to be effective. Acetaminophen (paracetamol) subcutaneous injection is performed in some centers despite the lack of conclusive evidence on its effectiveness. This study aims to evaluate the efficacy of subcutaneous infusion of Acetaminophen in the treatment of pain and fever in geriatrics and in palliative care and to determine its safety profile and possible side effects.

MATERIAL AND METHODS

This experimental study was conducted between 2018 and 2019 on adult patients in palliative care or in geriatrics in several hospitals and nursing homes in Lebanon. Primary outcomes were change in temperature; change in pain score on the numerical rating scale (NS) or on the Algoplus scale after 60 min from the start of the infusion; and the appearance of local side effects at the infusion site. Changes in the various parameters at 30 min and 180 min were also evaluated as secondary outcomes.

RESULTS

Thirty-one patients were included in the study, with a total of 120 doses of acetaminophen. At 60 min, the mean decrease in pain on the NS was 5.35 points, while the mean decrease in temperature was 0.79 degrees Celsius. At 60 min, 75%, CI = [47.62-92.73] of the patients who received acetaminophen for pain and 66.67%, CI = [38.38-88.17] of those who received it for fever had clinically significant improvement. The overall effect of subcutaneous acetaminophen, defined as any clinically significant effect on pain or fever, was 70.97%, CI = [51.96-85.78]. The overall effect at 30 min and at 180 min was 23.33%, CI = [9.93-42.28] and 87.10%, CI = [70.17-96.37], respectively. The side effects reported 30 min after the injection and observed after at least one of the doses were: local edema in 16 patients (51.61%), induration in one patient (3.23%), local pain in one patient (3.23%) and local heat in one patient (3.23%). At 180 min, only 2 patients (6.45%) still had edema at the infusion site.

CONCLUSION

Subcutaneous administration of acetaminophen is effective and well tolerated in geriatric and palliative care patients. It is appropriate when no other route is available, especially for home-based care. Comparative studies are needed to allow the expansion of this practice.

摘要

简介

皮下输注(SC)或皮下滴注是一种古老的灌注技术,尽管已证明其有效,但经常被超适应证使用。尽管缺乏关于其有效性的明确证据,但一些中心仍在进行对乙酰氨基酚(扑热息痛)的皮下注射。本研究旨在评估在老年病学和姑息治疗中皮下输注对乙酰氨基酚治疗疼痛和发热的疗效,并确定其安全性概况和可能的副作用。

材料和方法

这是一项在黎巴嫩几家医院和养老院的姑息治疗或老年病学成人患者中进行的 2018 年至 2019 年的实验性研究。主要结局是从输注开始后 60 分钟内体温的变化;输注开始后 60 分钟时数字评分量表(NS)或 Algoplus 量表上疼痛评分的变化;输注部位出现局部副作用。还评估了 30 分钟和 180 分钟时各参数的变化作为次要结局。

结果

共有 31 名患者入组,共接受了 120 剂对乙酰氨基酚。60 分钟时,NS 上疼痛的平均下降幅度为 5.35 分,而体温平均下降 0.79 摄氏度。60 分钟时,接受对乙酰氨基酚治疗疼痛的患者中有 75%(CI= [47.62-92.73]),接受对乙酰氨基酚治疗发热的患者中有 66.67%(CI= [38.38-88.17])有临床显著改善。定义为对疼痛或发热有任何临床显著影响的皮下乙酰氨基酚的总体效果为 70.97%(CI= [51.96-85.78])。30 分钟和 180 分钟的总体效果分别为 23.33%(CI= [9.93-42.28])和 87.10%(CI= [70.17-96.37])。注射后 30 分钟报告并至少在一次剂量后观察到的副作用为:16 名患者(51.61%)出现局部水肿,1 名患者(3.23%)出现硬结,1 名患者(3.23%)出现局部疼痛,1 名患者(3.23%)出现局部发热。180 分钟时,只有 2 名患者(6.45%)在输注部位仍有水肿。

结论

在老年病学和姑息治疗患者中,皮下给予对乙酰氨基酚是有效且耐受良好的。在没有其他途径可用时,特别是在家庭护理中,这种方法是合适的。需要进行比较研究,以扩大这种做法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4623/8961903/21ec0077d0bb/12904_2022_934_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验